<p>Provided herein are methods for treating or preventing ETS overexpressing castration-resistant prostate cancer, comprising administering an effective amount of a TOR kinase inhibitor to a patient having ETS overexpressing castration-resistant prostate cancer.</p>
申请公布号
PH12014502047(A1)
申请公布日期
2014.12.10
申请号
PH12014502047
申请日期
2014.09.15
申请人
SIGNAL PHARMACEUTICALS, LLC
发明人
XU, SHUICHAN;HEGE, KRISTEN, MAE;RAYMON, HEATHER;TSUJI, TOSHIYA;SAPINOSO, LISA